Commonwealth Consolidated Regulations Commonwealth Consolidated Regulationsmade under the
Narcotic Drugs Act 1967
Compilation No. 10
Compilation date: 1 July 2024
Includes amendments up to: F2024L00645
Registered: 1 July 2024
About this compilation
This compilation
This is a compilation of the Narcotic Drugs Regulation 2016 that shows the text of the law as amended and in force on 1 July 2024 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.
Self-repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
Part 1--Preliminary
1 Name
3 Authority
4 Definitions
4A Prescription of substances
4B Permitted supply
Part 2--Medicinal cannabis licences and permits
Division 1--Medicinal cannabis licences and permits
5 Application for medicinal cannabis licence--information requirements
6 Application for medicinal cannabis licence--document requirements
7 Application fee for medicinal cannabis licences
7A Application for medicinal cannabis licence--general grounds for refusal of licence
7B Matters to be specified in a medicinal cannabis licence--persons prescribed
8 Application for medicinal cannabis permit--information requirements
9 Application for medicinal cannabis permit--document requirements
10 Application fee for medicinal cannabis permit
11 Application for medicinal cannabis permit--particular grounds for refusal of permit
Division 3--Conditions of medicinal cannabis licences
17 Condition that medicinal cannabis licence holder must only use seeds, cultivars or other genetic material of cannabis plants obtained from legitimate sources
17A Condition that medicinal cannabis licence holder must give information relating to activities authorised by licence if requested
17B Condition that medicinal cannabis licence holder must retain records
17C Condition that medicinal cannabis licence holder must notify emergency services
17D Condition that medicinal cannabis licence holder must notify Secretary of certain information
17E Condition that medicinal cannabis licence holder must operate in accordance with risk management plan and standard operating procedures
17F Condition that medicinal cannabis licence holder must maintain system of security
18 Condition that medicinal cannabis licence holder employ or engage suitable staff
19 Condition that medicinal cannabis licence holder be party to certain contracts
20 Condition that medicinal cannabis licence holder notify the Secretary of certain matters
Division 4--Variation, suspension and surrender of medicinal cannabis licences and medicinal cannabis permits
Subdivision A--Variation of medicinal cannabis licences and medicinal cannabis permits
21 Circumstances in which medicinal cannabis licences and medicinal cannabis permits must not be varied
22 Application for variation of medicinal cannabis licences and medicinal cannabis permits--information requirements
23 Application for variation of medicinal cannabis licences and medicinal cannabis permits--document requirements
24 Application fee for variation of medicinal cannabis licences and medicinal cannabis permits
Subdivision B--Suspension of medicinal cannabis licences and medicinal cannabis permits
25 Suspension of medicinal cannabis licences and medicinal cannabis permits
26 Secretary may suspend medicinal cannabis licences and medicinal cannabis permits
27 Secretary may permit specified activities to occur during suspension of medicinal cannabis licences
27A Secretary may permit specified activities to occur during suspension of medicinal cannabis permits
28 Secretary to notify of proposed suspension of medicinal cannabis licences and medicinal cannabis permits
29 Effect of suspension of medicinal cannabis licences
29A Effect of suspension of medicinal cannabis permits
30 Revocation of suspension of medicinal cannabis licences and medicinal cannabis permits
31 Matters not affected by suspension of medicinal cannabis licences and medicinal cannabis permits
32 Offence and civil penalty--breach of condition of permitted activity during suspension of licence or permit
Subdivision C--Surrender of medicinal cannabis licences and medicinal cannabis permits
33 Surrender of medicinal cannabis licences and medicinal cannabis permits
34 Licence holder may surrender medicinal cannabis licences and medicinal cannabis permits
Part 3--Licensing the manufacturing of narcotic drugs
Division 1--Manufacture licences and permits
35 Application for manufacture licence--information requirements
36 Application for manufacture licence--document requirements
36A Application for manufacture licence--general grounds for refusal of licence
37 Matters to be specified in a manufacture licence--persons prescribed
38 Application for manufacture permit--information requirements
Division 2--Conditions of manufacture licences
39 Condition that manufacture licence holder employ or engage suitable staff
40 Condition that manufacture licence holder notify the Secretary of certain matters
Division 3--Variation, suspension and surrender of manufacture licences and manufacture permits
Subdivision A--Variation of manufacture licences and permits
41 Circumstances in which a manufacture licence or manufacture permit must not be varied
42 Application for variation of manufacture licence or permit--information requirements
43 Application for variation of manufacture licence or permit--document requirements
Subdivision B--Suspension of manufacture licences and permits
44 Suspension of manufacture licences and permits
45 Secretary may suspend manufacture licences and permits
46 Secretary to notify of proposed suspension of manufacture licence or permit
47 Effect of suspension of manufacture licences
47A Effect of suspension of manufacture permit
48 Revocation of suspension of manufacture licence or permit
49 Matters not affected by suspension of manufacture licence or permit
Subdivision C--Surrender of manufacture licences and permits
50 Surrender of manufacture licences and permits
51 Licence holder may surrender manufacture licence or permit
Part 4--Review of decisions
52 Reviewable decisions
Part 5--Other matters
Division 1--Inspection fees
54 Inspection fees
Division 1A--Charges
54A Classes of medicinal cannabis licences for the purposes of charge
54B Payment of charge
54C Recovery of charge
Division 2--Other matters
55 Secretary to notify States and Territories of certain matters
56 Modification of operation of Chapters 2 and 3 of the Act
Part 6--Application, saving and transitional provisions
57 Application provisions relating to the Narcotic Drugs Amendment (Cannabis) Regulations 2018
58 Application provisions relating to the Narcotic Drugs Amendment (Review Recommendations) Regulations 2019
59 Application provisions relating to the Narcotic Drugs Amendment (Fees) Regulations 2020
60 Application provisions relating to the Narcotic Drugs Amendment (Cannabis-Related Manufacture Licences and Permits) Regulations 2020
61 Application provisions relating to the Narcotic Drugs Amendment (Fees) Regulations 2021
62 Application provisions relating to the Narcotic Drugs Amendment (Medicinal Cannabis) Regulations 2021
63 Application of amendments of the Narcotic Drugs Amendment (Fees) Regulations 2023
64 Application provisions relating to the Narcotic Drugs Amendment (Fees) Regulations 2024
Schedule 1--Application fees
1 Table of fees
Endnotes
Endnote 1--About the endnotes
Endnote 2--Abbreviation key
Endnote 3--Legislation history
Endnote 4--Amendment history
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1--About the endnotes
Endnote 2--Abbreviation key
Endnote 3--Legislation history
Endnote 4--Amendment history
Abbreviation key--Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history--Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Editorial changes
The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.
If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.
If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and "(md not incorp)" is added to the amendment history.
ad = added or inserted | o = order(s) |
am = amended | Ord = Ordinance |
amdt = amendment | orig = original |
c = clause(s) | par = paragraph(s)/subparagraph(s) |
C[x] = Compilation No. x | /sub-subparagraph(s) |
Ch = Chapter(s) | pres = present |
def = definition(s) | prev = previous |
Dict = Dictionary | (prev ... ) = previously |
disallowed = disallowed by Parliament | Pt = Part(s) |
Div = Division(s) | r = regulation(s)/rule(s) |
ed = editorial change | reloc = relocated |
exp = expires/expired or ceases/ceased to have | renum = renumbered |
effect | rep = repealed |
F = Federal Register of Legislation | rs = repealed and substituted |
gaz = gazette | s = section(s)/subsection(s) |
LA = Legislation Act 2003 | Sch = Schedule(s) |
Sdiv = Subdivision(s) | |
(md) = misdescribed amendment can be given | SLI = Select Legislative Instrument |
effect | SR = Statutory Rules |
(md not incorp) = misdescribed amendment | Sub-Ch = Sub-Chapter(s) |
cannot be given effect | SubPt = Subpart(s) |
mod = modified/modification | underlining = whole or part not |
No. = Number(s) | commenced or to be commenced |
Endnote 3--Legislation history
Name | Registration | Commencement | Application, saving and transitional provisions |
14 Oct 2016 (F2016L01613) | 29 Oct 2016 (s 2(1) item 1) |
| |
Narcotic Drugs Amendment (Licence Charges) Regulation 2016 | 9 Dec 2016 (F2016L01894) | 10 Dec 2016 (s 2(1) item 1) | -- |
Narcotic Drugs Amendment (Cannabis) Regulations 2018 | 13 Feb 2018 (F2018L00106) | 14 Feb 2018 (s 2(1) item 1) | -- |
Narcotic Drugs Amendment (Review Recommendations) Regulations 2019 | 20 Nov 2019 (F2019L01485) | 1 Jan 2020 (s 2(1) item 1) | -- |
Narcotic Drugs Amendment (Fees) Regulations 2020 | 10 July 2020 (F2020L00904) | 15 July 2020 (s 2(1) item 1) | -- |
Narcotic Drugs Amendment (Cannabis-Related Manufacture Licences and Permits) Regulations 2020 | 20 Oct 2020 (F2020L01328) | 1 Nov 2020 (s 2(1) item 1) | -- |
Narcotic Drugs Amendment (Fees) Regulations 2021 | 15 June 2021 (F2021L00757) | 1 July 2021 (s 2(1) item 1) | -- |
Narcotic Drugs Amendment (Medicinal Cannabis) Regulations 2021 | 10 Dec 2021 (F2021L01751) | 24 Dec 2021 (s 2(1) item 1) | -- |
Therapeutic Goods Legislation Amendment (2022 Measures No. 1) Regulations 2022 | 4 Mar 2022 (F2022L00243) | Sch 1 (items 1, 2): 31 Mar 2022 (s 2(1) item 2) | -- |
Narcotic Drugs Amendment (Fees) Regulations 2023 | 21 July 2023 (F2023L01026) | 1 Aug 2023 (s 2(1) item 1) | -- |
Narcotic Drugs Amendment (Fees) Regulations 2024 | 6 June 2024 (F2024L00645) | 1 July 2024 (s 2(1) item 1) | -- |
Provision affected | How affected |
Part 1 |
|
s 2..................... | rep LA s 48D |
s 4..................... | am F2019L01485; F2020L00904; F2020L01328; F2021L01751; F2023L01026; F2024L00645 |
s 4A.................... | ad F2018L00106 |
| am F2019L01485 |
s 4B.................... | ad F2021L01751 |
| am F2022L00243 |
Part 2 |
|
Part 2 heading............. | rs F2021L01751 |
Division 1 |
|
s 5..................... | am F2018L00106; F2019L01485; F2021L01751 |
| ed C7 |
s 6..................... | am F2021L01751; F2024L00645 |
s 7A.................... | ad F2018L00106 |
| rs F2019L01485 |
| am F2021L01751 |
s 7B.................... | ad F2018L00106 |
| am F2019L01485 |
| rs F2021L01751 |
s 8..................... | am F2019L01485; F2021L01751 |
s 9..................... | am F2019L01485 |
| rs F2021L01751 |
s 10.................... | rs F2023L01026 |
s 11.................... | am F2016L01894; F2018L00106; F2019L01485 |
| rs F2021L01751 |
| am F2022L00243 |
Division 2................ | rep F2021L01751 |
s 12.................... | rep F2021L01751 |
s 13.................... | rep F2021L01751 |
s 13A................... | ad F2018L00106 |
| rs F2019L01485 |
| rep F2021L01751 |
s 14.................... | am F2018L00106; F2019L01485 |
| rep F2021L01751 |
s 15.................... | am F2018L00106 |
| rep F2019L01485 |
s 16.................... | rep F2021L01751 |
s 17.................... | am F2019L01485 |
| rep F2021L01751 |
Division 3 |
|
Division 3 heading .......... | am F2021L01751 |
s 17.................... | ad F2021L01751 |
s 17A................... | ad F2021L01751 |
s 17B................... | ad F2021L01751 |
s 17C................... | ad F2021L01751 |
s 17D................... | ad F2021L01751 |
s 17E................... | ad F2021L01751 |
s 17F................... | ad F2021L01751 |
s 18.................... | am F2021L01751 |
s 19.................... | am F2018L00106; F2019L01485; F2021L01751 |
s 20.................... | am F2018L00106; F2021L01751 |
| ed C7 |
Division 4 |
|
Division 4 heading.......... | am F2021L01751 |
Subdivision A |
|
Subdivision A heading........ | am F2021L01751 |
s 21.................... | rs F2021L01751 |
s 22.................... | am F2021L01751 |
s 23.................... | am F2021L01751 |
s 24.................... | am F2021L01751 |
| rs F2023L01026 |
Subdivision B |
|
Subdivision B heading........ | am F2021L01751 |
s 25.................... | am F2021L01751 |
s 26.................... | am F2021L01751 |
s 27.................... | rs F2021L01751 |
s 27A................... | ad F2021L01751 |
s 28.................... | am F2018L00106; F2021L01751 |
s 29.................... | rs F2021L01751 |
s 29A................... | ad F2021L01751 |
s 30.................... | am F2021L01751 |
s 31.................... | am F2021L01751 |
s 32.................... | am F2021L01751 |
Subdivision C |
|
Subdivision C heading........ | am F2021L01751 |
s 33.................... | am F2021L01751 |
s 34.................... | am F2019L01485; F2021L01751 |
Part 3 |
|
Part 3 heading............. | am F2021L01751 |
Division 1 |
|
s 35.................... | am F2018L00106; F2019L01485; F2020L01328; F2021L01751 |
s 36.................... | am F2018L00106; F2024L00645 |
s 36AA.................. | ad F2020L01328 |
| rep F2021L01751 |
s 36A................... | ad F2018L00106 |
| rs F2019L01485 |
s 37.................... | rs F2018L00106 |
| am F2019L01485 |
| rs F2021L01751 |
s 38.................... | am F2018L00106; F2021L01751 |
s 38A................... | ad F2020L01328 |
| rep F2021L01751 |
Division 2 |
|
s 39.................... | am F2021L01751 |
s 40.................... | am F2018L00106; F2021L01751 |
Division 3 |
|
Subdivision A |
|
s 41.................... | rs F2021L01751 |
s 43A................... | ad F2020L01328 |
| rep F2021L01751 |
Subdivision B |
|
s 44.................... | am F2021L01751 |
s 45.................... | am F2021L01751 |
s 46.................... | am F2018L00106; F2021L01751 |
s 47.................... | rs F2021L01751 |
s 47A................... | ad F2021L01751 |
s 49.................... | am F2021L01751 |
Subdivision C |
|
s 51.................... | am F2019L01485; F2021L01751 |
Part 4 |
|
s 52.................... | am F2016L01894; F2020L01328; F2021L01751 |
Part 5 |
|
Division 1 |
|
Division 1 heading.......... | rs F2020L00904 |
s 53.................... | rep F2020L00904 |
s 54.................... | am F2020L00904; F2021L00757; F2021L01751; F2023L01026; F2024L00645 |
Division 1A |
|
Division 1A............... | ad F2016L01894 |
s 54A................... | ad F2016L01894 |
| rs F2021L01751 |
s 54AA.................. | ad F2020L01328 |
| rep F2021L01751 |
s 54AB.................. | ad F2020L01328 |
| rep F2021L01751 |
s 54B................... | ad F2016L01894 |
| rs F2020L00904 |
| am F2023L01026 |
s 54C................... | ad F2016L01894 |
| am F2020L00904 |
Division 2 |
|
s 55.................... | am F2021L01751 |
s 56.................... | ad F2018L00106 |
| am F2021L01751 |
Part 6 |
|
Part 6................... | ad F2018L00106 |
s 57.................... | ad F2018L00106 |
s 58.................... | ad F2019L01485 |
s 59.................... | ad F2020L00904 |
s 60.................... | ad F2020L01328 |
s 61.................... | ad F2021L00757 |
s 62.................... | ad F2021L01751 |
s 63.................... | ad F2023L01026 |
s 64.................... | ad F2024L00645 |
Schedule 1 |
|
Schedule 1 heading.......... | am F2020L00904 |
Schedule 1................ | am F2020L00904; F2020L01328 |
| rs F2021L01751 |
c 1..................... | am F2018L00106; F2020L00904; F2020L01328; F2021L00757; F2023L01026; F2024L00645 |